Skip to content

Comparison of treatment of Volar Barton fracture with T plate using distal end screws and without distal end screws

Comparison of treatment of Volar Barton fracture with T plate using distal end screws and without distal end screws

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20221231056999N1
Enrollment
60
Registered
2023-02-20
Start date
2023-03-01
Completion date
Unknown
Last updated
2023-03-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Volar barton Fracture.

Interventions

Intervention 1: The Modified Henry approach (Trans-FCR) was used to expose the fracture. Skin incision was made over flexor Carpi radialis tendon and incising the tendon sheath. FCR tendon was exposed

Sponsors

Mayo Hospital, Lahore
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Patients having closed volar Barton’s fracture with Mehara classification types-1 & II. Presenting within 5 days of fracture.

Exclusion criteria

Exclusion criteria: Patients with infections, extensive comminution, open fracture with extensive soft tissue damage or contamination, neurological deficit, head injury or major vascular injury, ipsilateral upper limb trauma or those non-compliant to postoperative physiotherapy and follow up. Patients with severe osteoporosis or those with reduced functional requirement of wrist were also excluded.

Design outcomes

Primary

MeasureTime frame
Functional outcome as per Green & O'Brien Score. This is an examiner-rated assessment of pain, functional status, range of motion, and grip strength. Each of the 4 parameters is given a weighting of 25 points, giving a total score of 100. With excellent being 90 to 100, good 80 to 89, fair 65 to 79, and poor <65. Timepoint: 0-days, 14th day, 28th day, 90th day. Method of measurement: functional outcomes as per Green & O’Brien Scoring.;Pain, healing and callous formation. Timepoint: 0-days, 14th day, 28th day, 90th day. Method of measurement: Clinical and physical examination.

Countries

Pakistan

Contacts

Public ContactMuhammad Aamir

RESnTEC

aamir@resntec.com+92 321 6801143

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 5, 2026